Foley Senior Counsel R. Brian McCaslin authored an article titled “Are Patent Offices Ready for Personalized Medicine?” in the March/April 2009 issue of Bio-IT World. McCaslin discusses the unique challenges to the patent system presented by new sciences such as personalized medicine, stating that innovators seeking to patent new sciences should consider adapting their prosecution strategy to the current administrative landscape. He adds that innovators should consider postponing the filing date of an application until more information about the new science can be obtained.
Related Insights
23 December 2024
Labor & Employment Law Perspectives
Regulating Artificial Intelligence in Employment Decision-Making: What’s on the Horizon for 2025
Share on TwitterShare by EmailShareBack to topEmployment law in 2024 could aptly be summarized as the “Year of Artificial Intelligence Legislation.
23 December 2024
Injunction Stayed: Corporate Transparency Act Enforcement Resumes
The U.S. Department of Justice scored a victory in ongoing litigation over the constitutionality of the Corporate Transparency Act (CTA) when the Fifth Circuit Court of Appeals stayed the nationwide preliminary injunction issued earlier this month by a federal district court in Texas.
23 December 2024
Health Care Law Today
Medicare Telehealth Flexibilities Get a Three-Month Lifeline
Share on TwitterShare by EmailShareBack to topAfter much uncertainty, Congress has extended many Medicare telehealth flexibilities through March 31, 2025, in its end-of-year appropriations bill.